Background Most patients with nonsmall-cell lung cancer have no response to the tyrosine kinase inhibitor gefitinib, which targets the epidermal growth factor ...
Inquire NowInnovation and Entrepreneurship Research on Model of Digital Enterprises Information Resources Management System Jianjun Sun and Huiping Cheng
Inquire Now